Profits made by giants like Mc.Donalds and Walt Disney along with a a parade of stronger-than-expected profit reports from US ...

LifeMD shares plummeted Wednesday after the telehealth outlet acknowledged higher customer acquisition costs hit hard in the ...

Q2 2025 Earnings Call Transcript August 4, 2025 Medifast, Inc. beats earnings expectations. Reported EPS is $0.04, ...

Key Points Revenue grew 23% year over year (GAAP) in Q2 2025, but missed analyst estimates by $4.1 million (GAAP). The telehealth segment achieved 30.0% revenue growth, with Adjusted EBITDA rising 560 ...

The company slashed its full-year 2025 revenue guidance to $250-255 million from its previous forecast of $268-275 million, well below analyst expectations of $270.4 million. For the third quarter, ...

Treace Medical Concepts, Inc. ('Treace” or the 'Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot ...

Key Points GAAP revenue beat expectations at $105.6 million for Q2 2025 but was down 37.4% year over year. GAAP earnings per share rose to $0.22 for Q2 2025, including a $2.0 million net-of-tax ...

Analysts estimate that LifeMD will report an earnings per share (EPS) of $0.10. The market awaits LifeMD's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance ...

LifeMD Inc (NASDAQ:LFMD) is set to release its Q2 2025 earnings on Aug 5, 2025. The consensus estimate for Q2 2025 revenue is ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Growth Conference, which will be held August 12 ...